GILEAD SCIENCES INC's ticker is and the CUSIP is 375558AP8. A total of 63 filers reported holding GILEAD SCIENCES INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $37,587,000 | -8.7% | 9,115,000 | 0.0% | 0.04% | -6.4% |
| Q4 2015 | $41,176,000 | +20.2% | 9,115,000 | +15.3% | 0.05% | +23.7% |
| Q3 2015 | $34,262,000 | -25.5% | 7,905,000 | -11.2% | 0.04% | -13.6% |
| Q2 2015 | $46,009,000 | +13.1% | 8,905,000 | -5.3% | 0.04% | +12.8% |
| Q1 2015 | $40,665,000 | -37.8% | 9,405,000 | -40.1% | 0.04% | -37.1% |
| Q4 2014 | $65,338,000 | -25.6% | 15,705,000 | -16.0% | 0.06% | -28.7% |
| Q3 2014 | $87,836,000 | +7.9% | 18,705,000 | -16.3% | 0.09% | +6.1% |
| Q2 2014 | $81,422,000 | -3.0% | 22,335,000 | -17.2% | 0.08% | -8.9% |
| Q1 2014 | $83,901,000 | +11.6% | 26,970,000 | +18.3% | 0.09% | +4.7% |
| Q4 2013 | $75,167,000 | +14.1% | 22,800,000 | -4.2% | 0.09% | +6.2% |
| Q3 2013 | $65,867,000 | +15.0% | 23,800,000 | -5.9% | 0.08% | +9.5% |
| Q2 2013 | $57,286,000 | – | 25,300,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INCOME RESEARCH & MANAGEMENT | 8,446,000 | $36,207,000 | 5.88% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 6,200,000 | $26,579,000 | 2.70% |
| AEGON USA Investment Management, LLC | 2,500,000 | $10,717,000 | 2.58% |
| MACKAY SHIELDS LLC | 10,243,000 | $43,930,000 | 2.29% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,100,000 | $4,718,000 | 2.05% |
| MUFG Securities EMEA plc | 1,055,000 | $4,569,000 | 1.75% |
| SSI INVESTMENT MANAGEMENT LLC | 3,222,000 | $13,981,000 | 1.50% |
| LAFFER TENGLER INVESTMENTS, INC. | 1,097 | $4,756,428,000 | 1.26% |
| CQS Cayman LP | 3,300,000 | $14,229,000 | 1.18% |
| CNO Financial Group, Inc. | 500,000 | $2,143,000 | 0.87% |